{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:25:17Z","timestamp":1792783517218,"version":"4.5.0"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["OPUS 18, grant no. 2019\/35\/B\/NZ5\/01445"],"award-info":[{"award-number":["OPUS 18, grant no. 2019\/35\/B\/NZ5\/01445"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["OPUS 18, grant no. 2019\/35\/B\/NZ5\/01445"],"award-info":[{"award-number":["OPUS 18, grant no. 2019\/35\/B\/NZ5\/01445"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["OPUS 18, grant no. 2019\/35\/B\/NZ5\/01445"],"award-info":[{"award-number":["OPUS 18, grant no. 2019\/35\/B\/NZ5\/01445"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Narodowe Centrum Nauki , Polska","award":["MINIATURA 7, grant no. 2023\/07\/X\/NZ3\/01064"],"award-info":[{"award-number":["MINIATURA 7, grant no. 2023\/07\/X\/NZ3\/01064"]}],"id":[{"id":"https:\/\/ror.org\/03ha2q922","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ferroptosis is an iron-dependent form of regulated cell death driven by phospholipid peroxidation and the failure of cellular antioxidant defenses. Its close integration with iron metabolism, lipid remodeling, and redox homeostasis has identified ferroptosis as a potentially exploitable vulnerability in cancer. This review critically examines the molecular and pharmacological determinants of ferroptotic sensitivity, including iron handling, acyl-CoA synthetase long-chain family member 4 (ACSL4)\/lysophosphatidylcholine acyltransferase 3 (LPCAT3)-dependent lipid remodeling, and the glutathione peroxidase 4 (GPX4)\u2013glutathione, ferroptosis suppressor protein 1 (FSP1)\u2013coenzyme Q10, mitochondrial dihydroorotate dehydrogenase (DHODH), and GTP cyclohydrolase 1 (GCH1)\u2013tetrahydrobiopterin defense systems. We discuss experimental ferroptosis inducers and clinically used drugs with reported ferroptosis-modulating activity, emphasizing differences in their mechanisms, strength of evidence, and translational relevance. Particular attention is given to the bidirectional interactions between ferroptosis and the tumor immune microenvironment. Although cytotoxic lymphocytes and interferon-gamma (IFN-\u03b3) signaling may sensitize malignant cells to ferroptosis, excessive lipid peroxidation in cluster of differentiation 8-positive (CD8\u207a) T cells, natural killer cells, dendritic cells, and other immune populations may impair antitumor immunity. These context- and cell-type-dependent effects support combination strategies involving immunotherapy, radiotherapy, and conventional or targeted anticancer treatments, but also define potential toxicities. We further discuss candidate biomarkers related to iron metabolism, lipid composition, antioxidant capacity, and immune context, as well as the need for patient stratification and targeted drug delivery. Successful clinical implementation will require selective induction of ferroptosis in malignant cells while preserving normal tissues and antitumor immune function. Ferroptosis should therefore be regarded as a conditional therapeutic vulnerability rather than a universally beneficial anticancer mechanism.<\/jats:p>","DOI":"10.1007\/s43440-026-00910-1","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:11:39Z","timestamp":1790316699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological targeting of ferroptosis in cancer: mechanisms, tumor immunity, and translational challenges"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-2608","authenticated-orcid":false,"given":"Aleksandra","family":"Zdanowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2751-1428","authenticated-orcid":false,"given":"Bhaskar","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-618X","authenticated-orcid":false,"given":"Beata","family":"Pyrzy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3378-4169","authenticated-orcid":false,"given":"Dagmara","family":"Otto-\u015alusarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0181-3607","authenticated-orcid":false,"given":"Marta","family":"Struga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"910_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"910_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"910_CR3","doi-asserted-by":"publisher","first-page":"216152","DOI":"10.1016\/j.canlet.2023.216152","volume":"561","author":"S Zheng","year":"2023","unstructured":"Zheng S, Guan XY, Ferroptosis. Promising approach for cancer and cancer immunotherapy. Cancer Lett. 2023;561:216152.","journal-title":"Cancer Lett"},{"key":"910_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2023.10.011","volume":"31","author":"J Rodencal","year":"2024","unstructured":"Rodencal J, Kim N, He A, Li VL, Lange M, He J, et al. Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest. Cell Chem Biol. 2024;31:234\u2013e24813.","journal-title":"Cell Chem Biol"},{"key":"910_CR5","doi-asserted-by":"publisher","first-page":"1075704","DOI":"10.3389\/fmolb.2023.1075704","volume":"10","author":"S Nikulin","year":"2023","unstructured":"Nikulin S, Razumovskaya A, Poloznikov A, Zakharova G, Alekseev B, Tonevitsky A. ELOVL5 and IGFBP6 genes modulate sensitivity of breast cancer cells to ferroptosis. Front Mol Biosci. 2023;10:1075704.","journal-title":"Front Mol Biosci"},{"key":"910_CR6","doi-asserted-by":"publisher","first-page":"2411247","DOI":"10.1002\/adfm.202411247","volume":"34","author":"Z Li","year":"2024","unstructured":"Li Z, He S, Xie L, Zeng G, Huang J, Wang H, et al. Boosting Ferroptosis and immunotherapy for Colorectal Cancer by Lactate-Related Metabolic Reprogramming. Adv Funct Mater. 2024;34:2411247.","journal-title":"Adv Funct Mater"},{"key":"910_CR7","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1038\/s41467-022-32066-w","volume":"13","author":"W Wang","year":"2022","unstructured":"Wang W, Zheng H, Jiang J, Li Z, Jiang D, Shi X, et al. Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments. Nat Commun. 2022;13:4495.","journal-title":"Nat Commun"},{"key":"910_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley MA, Kremer DM, Maurer HC, DelGiorno KE, Lee HJ, Purohit V, et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science. 2020;368:85\u20139.","journal-title":"Science"},{"key":"910_CR9","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 2019;9:1673\u201385.","journal-title":"Cancer Discov"},{"key":"910_CR10","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185:2401\u201321.","journal-title":"Cell"},{"key":"910_CR11","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cells9061505","volume":"9","author":"AM Battaglia","year":"2020","unstructured":"Battaglia AM, Chirillo R, Aversa I, Sacco A, Costanzo F, Biamonte F. Ferroptosis and cancer: mitochondria meet the iron maiden cell death. Cells. 2020;9:1505.","journal-title":"Cells"},{"key":"910_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","volume":"6","author":"HF Yan","year":"2021","unstructured":"Yan HF, Zou T, Tuo QZ, Xu S, Li H, Belaidi AA, et al. Ferroptosis: mechanisms and links with diseases. Signal Transduct Target Ther. 2021;6:49.","journal-title":"Signal Transduct Target Ther"},{"key":"910_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41580-020-0241-0","volume":"21","author":"H Nakatogawa","year":"2020","unstructured":"Nakatogawa H. Mechanisms governing autophagosome biogenesis. Nat Rev Mol Cell Biol. 2020;21:439\u201358.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"910_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2020.02.005","volume":"27","author":"J Liu","year":"2020","unstructured":"Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D. Autophagy-dependent ferroptosis: machinery and regulation. Cell Chem Biol. 2020;27:420\u201335.","journal-title":"Cell Chem Biol"},{"key":"910_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol. 2018;19:349\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"910_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.immuni.2021.01.018","volume":"54","author":"V Deretic","year":"2021","unstructured":"Deretic V. Autophagy in inflammation, infection, and immunometabolism. Immunity. 2021;54:437\u201353.","journal-title":"Immunity"},{"key":"910_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1600-6143.2011.03771.x","volume":"12","author":"M Tanemura","year":"2012","unstructured":"Tanemura M, Ohmura Y, Deguchi T, Machida T, Tsukamoto R, Wada H, et al. Rapamycin causes upregulation of autophagy and impairs islets function both in vitro and in vivo. Am J Transpl. 2012;12:102\u201314.","journal-title":"Am J Transpl"},{"key":"910_CR18","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nchembio.79","volume":"4","author":"A Williams","year":"2008","unstructured":"Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, et al. Novel targets for Huntington\u2019s disease in an mTOR-independent autophagy pathway. Nat Chem Biol. 2008;4:295\u2013305.","journal-title":"Nat Chem Biol"},{"key":"910_CR19","first-page":"1384","volume":"10","author":"B Singha","year":"2020","unstructured":"Singha B, Laski J, Vald\u00e9s YR, Liu E, DiMattia GE, Shepherd TG. Inhibiting ULK1 kinase decreases autophagy and cell viability in high-grade serous ovarian cancer spheroids. Am J Cancer Res. 2020;10:1384\u201399.","journal-title":"Am J Cancer Res"},{"key":"910_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2011.08.037","volume":"147","author":"J Liu","year":"2011","unstructured":"Liu J, Xia H, Kim M, Xu L, Li Y, Zhang L, et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell. 2011;147:223\u201334.","journal-title":"Cell"},{"key":"910_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/ars.2022.0202","volume":"39","author":"F Chen","year":"2023","unstructured":"Chen F, Cai X, Kang R, Liu J, Tang D. Autophagy-dependent ferroptosis in cancer. Antioxid Redox Signal. 2023;39:79\u2013101.","journal-title":"Antioxid Redox Signal"},{"key":"910_CR22","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41419-024-06712-8","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, Li X, Yang M, Liu SB. Research progress on morphology and mechanism of programmed cell death. Cell Death Dis. 2024;15:327.","journal-title":"Cell Death Dis"},{"key":"910_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12967-024-06059-w","volume":"23","author":"X Liu","year":"2025","unstructured":"Liu X, et al. Crosstalk between ferroptosis and autophagy: broaden horizons of cancer therapy. J Transl Med. 2025;23:18.","journal-title":"J Transl Med"},{"key":"910_CR24","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ccell.2019.04.002","volume":"35","author":"B Hassannia","year":"2019","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell. 2019;35:830\u201349.","journal-title":"Cancer Cell"},{"key":"910_CR25","first-page":"8","volume":"34","author":"S Yin","year":"2025","unstructured":"Yin S, Li Z, Ou WB, Ferroptosis. Mechanisms, Comparison with Cuproptosis and Emerging Horizons in Therapeutics. Oncol Res. 2025;34:8.","journal-title":"Oncol Res"},{"key":"910_CR26","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/antiox12040918","volume":"12","author":"J Lee","year":"2023","unstructured":"Lee J, Hyun DH. The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases. Antioxid (Basel). 2023;12:918.","journal-title":"Antioxid (Basel)"},{"key":"910_CR27","doi-asserted-by":"publisher","first-page":"102365","DOI":"10.1016\/j.redox.2022.102365","volume":"54","author":"DC Fuhrmann","year":"2022","unstructured":"Fuhrmann DC, Br\u00fcne B. A graphical journey through iron metabolism, microRNAs, and hypoxia in ferroptosis. Redox Biol. 2022;54:102365.","journal-title":"Redox Biol"},{"key":"910_CR28","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J Liu","year":"2022","unstructured":"Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2022;289:7038\u201350.","journal-title":"FEBS J"},{"key":"910_CR29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41418-019-0352-3","volume":"27","author":"GQ Chen","year":"2020","unstructured":"Chen GQ, Benthani FA, Wu J, Liang D, Bian ZX, Jiang X. Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell Death Differ. 2020;27:242\u201354.","journal-title":"Cell Death Differ"},{"key":"910_CR30","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nchem.2778","volume":"9","author":"TT Mai","year":"2017","unstructured":"Mai TT, Hama\u00ef A, Hienzsch A, Ca\u00f1eque T, M\u00fcller S, Wicinski J, et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat Chem. 2017;9:1025\u201333.","journal-title":"Nat Chem"},{"key":"910_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41589-018-0031-6","volume":"14","author":"MM Gaschler","year":"2018","unstructured":"Gaschler MM, Andia AA, Liu H, Csuka JM, Hurlocker B, Vaiana CA, et al. FINO2 initiates ferroptosis through GPX4 inactivation and iron oxidation. Nat Chem Biol. 2018;14:507\u201315.","journal-title":"Nat Chem Biol"},{"key":"910_CR32","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1182\/blood.V82.12.3610.3610","volume":"82","author":"GL Wang","year":"1993","unstructured":"Wang GL, Semenza GL. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood. 1993;82:3610\u20135.","journal-title":"Blood"},{"key":"910_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ygyno.2022.05.006","volume":"166","author":"N Zhou","year":"2022","unstructured":"Zhou N, Cui Y, Zhu R, Kuang Y, Ma W, Hou J, et al. Deferasirox shows inhibition activity against cervical cancer in vitro and in vivo. Gynecol Oncol. 2022;166:126\u201337.","journal-title":"Gynecol Oncol"},{"key":"910_CR34","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.bcp.2012.02.002","volume":"83","author":"CZ Zhang","year":"2012","unstructured":"Zhang CZ, Zhang H, Yun J, Chen GG, San Lai PB. Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo. Biochem Pharmacol. 2012;83:1278\u201389.","journal-title":"Biochem Pharmacol"},{"key":"910_CR35","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nchem.2778","volume":"9","author":"T Mai","year":"2017","unstructured":"Mai T, Hama\u00ef A, Hienzsch A, Caneque T, M\u00fcller S, Wicinski J, et al. Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat Chem. 2017;9:1025\u201333.","journal-title":"Nat Chem"},{"key":"910_CR36","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1002\/chem.202000159","volume":"26","author":"AL Turcu","year":"2020","unstructured":"Turcu AL, Versini A, Khene N, Gaillet C, Ca\u00f1eque T, M\u00fcller S, et al. DMT1 inhibitors kill cancer stem cells by blocking lysosomal iron translocation. Chemistry. 2020;26:7369\u201373.","journal-title":"Chemistry"},{"key":"910_CR37","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.7150\/thno.101821","volume":"15","author":"S Ovejero","year":"2025","unstructured":"Ovejero S, Alibert L, Devin J, Caneque T, Jacquier V, Romero A, et al. Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addiction. Theranostics. 2025;15:2834\u201351.","journal-title":"Theranostics"},{"key":"910_CR38","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1021\/acschembio.5b00900","volume":"11","author":"RP Abrams","year":"2016","unstructured":"Abrams RP, Carroll WL, Woerpel K. Five-membered ring peroxide selectively initiates ferroptosis in cancer cells. ACS Chem Biol. 2016;11:1305\u201312.","journal-title":"ACS Chem Biol"},{"key":"910_CR39","doi-asserted-by":"publisher","first-page":"e2307","DOI":"10.1038\/cddis.2016.208","volume":"7","author":"S Ma","year":"2016","unstructured":"Ma S, Henson ES, Chen Y, Gibson SB. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis. 2016;7:e2307.","journal-title":"Cell Death Dis"},{"key":"910_CR40","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41419-022-05007-0","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu X, Sheng H, Zhao L, Jiang M, Lou H, Miao Y, et al. Co-loaded lapatinib\/PAB by ferritin nanoparticles eliminated ECM-detached cluster cells via modulating EGFR in triple-negative breast cancer. Cell Death Dis. 2022;13:557.","journal-title":"Cell Death Dis"},{"key":"910_CR41","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1172\/JCI99032","volume":"128","author":"B Hassannia","year":"2018","unstructured":"Hassannia B, Wiernicki B, Ingold I, Qu F, Van Herck S, Tyurina YY, et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J Clin Invest. 2018;128:3341\u201355.","journal-title":"J Clin Invest"},{"key":"910_CR42","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/pin.12665","volume":"68","author":"T Furuta","year":"2018","unstructured":"Furuta T, Shi L, Toyokuni S. Non-thermal plasma as a simple ferroptosis inducer in cancer cells: A possible role of ferritin. Pathol Int. 2018;68:442\u20133.","journal-title":"Pathol Int"},{"key":"910_CR43","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12964-023-01382-z","volume":"22","author":"S Peng","year":"2024","unstructured":"Peng S, Chen G, Yu K, Feng Y, Zhao L, Yang M, et al. Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS\/AMPK\/mTOR axis in lung cancer cells. Cell Commun Signal. 2024;22:112.","journal-title":"Cell Commun Signal"},{"key":"910_CR44","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.apsb.2021.05.006","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu Y, Song Z, Liu Y, Ma X, Wang W, Ke Y, et al. Identification of ferroptosis as a novel mechanism for antitumor activity of natural product derivative a2 in gastric cancer. Acta Pharm Sin B. 2021;11:1513\u201325.","journal-title":"Acta Pharm Sin B"},{"key":"910_CR45","first-page":"83","volume":"10","author":"MJ Kim","year":"2021","unstructured":"Kim MJ, Yun GJ, Kim SE. Metabolic regulation of ferroptosis in cancer. Biology (Basel). 2021;10:83.","journal-title":"Biology (Basel)"},{"key":"910_CR46","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"910_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.plipres.2018.11.001","volume":"73","author":"NK Singh","year":"2019","unstructured":"Singh NK, Rao GN. Emerging role of 12\/15-Lipoxygenase (ALOX15) in human pathologies. Prog Lipid Res. 2019;73:28\u201345.","journal-title":"Prog Lipid Res"},{"key":"910_CR48","first-page":"184","volume":"10","author":"JY Lee","year":"2021","unstructured":"Lee JY, Kim WK, Bae KH, Lee SC, Lee EW. Lipid metabolism and ferroptosis. Biology (Basel). 2021;10:184.","journal-title":"Biology (Basel)"},{"key":"910_CR49","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/cells9061529","volume":"9","author":"M Fiorillo","year":"2020","unstructured":"Fiorillo M, T\u00f3th F, Brindisi M, Sotgia F, Lisanti MP. Deferiprone (DFP) targets cancer stem cell (CSC) propagation by inhibiting mitochondrial metabolism and inducing ROS production. Cells. 2020;9:1529.","journal-title":"Cells"},{"key":"910_CR50","doi-asserted-by":"publisher","first-page":"112434","DOI":"10.1016\/j.biopha.2021.112434","volume":"145","author":"KR Kakularam","year":"2022","unstructured":"Kakularam KR, Karst F, Polamarasetty A, Ivanov I, Heydeck D, Kuhn H. Paralog-and ortholog-specificity of inhibitors of human and mouse lipoxygenase-isoforms. Biomed Pharmacother. 2022;145:112434.","journal-title":"Biomed Pharmacother"},{"key":"910_CR51","doi-asserted-by":"publisher","first-page":"6743","DOI":"10.7150\/thno.43938","volume":"10","author":"Y Kuai","year":"2020","unstructured":"Kuai Y, Liu H, Liu D, Liu Y, Sun Y, Xie J, et al. An ultralow dose of the NADPH oxidase inhibitor diphenyleneiodonium (DPI) is an economical and effective therapeutic agent for the treatment of colitis-associated colorectal cancer. Theranostics. 2020;10:6743\u201357.","journal-title":"Theranostics"},{"key":"910_CR52","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.7150\/jca.81099","volume":"14","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Luan Q, Hao W, Cui Y, Li Y, Li X. NOX4-derived ROS regulates aerobic glycolysis of breast cancer through YAP pathway. J Cancer. 2023;14:2562\u201373.","journal-title":"J Cancer"},{"key":"910_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3324\/haematol.2020.259531","volume":"107","author":"R Birsen","year":"2021","unstructured":"Birsen R, Larrue C, Decroocq J, Johnson N, Guiraud N, Gotanegre M, et al. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica. 2021;107:403\u201316.","journal-title":"Haematologica"},{"key":"910_CR54","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41419-021-03516-y","volume":"12","author":"S Huang","year":"2021","unstructured":"Huang S, Cao B, Zhang J, Feng Y, Wang L, Chen X, et al. Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential. Cell Death Dis. 2021;12:237.","journal-title":"Cell Death Dis"},{"key":"910_CR55","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1007\/s10495-024-01973-2","volume":"29","author":"Z Shen","year":"2024","unstructured":"Shen Z, Zhao L, Yoo SA, Lin Z, Zhang Y, Yang W, et al. Emodin induces ferroptosis in colorectal cancer through NCOA4-mediated ferritinophagy and NF-\u03bab pathway inactivation. Apoptosis. 2024;29:1810\u201323.","journal-title":"Apoptosis"},{"key":"910_CR56","doi-asserted-by":"publisher","first-page":"834729","DOI":"10.3389\/fonc.2022.834729","volume":"12","author":"X Liang","year":"2022","unstructured":"Liang X, Hu C, Han M, Liu C, Sun X, Yu K, et al. Solasonine inhibits pancreatic cancer progression with involvement of ferroptosis induction. Front Oncol. 2022;12:834729.","journal-title":"Front Oncol"},{"key":"910_CR57","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.1245\/s10434-020-09334-4","volume":"28","author":"Y Shishido","year":"2021","unstructured":"Shishido Y, Amisaki M, Matsumi Y, Yakura H, Nakayama Y, Miyauchi W, et al. Antitumor Effect of 5-Aminolevulinic Acid Through Ferroptosis in Esophageal Squamous Cell Carcinoma: Y. Shishido et al. Ann Surg Oncol. 2021;28:3996\u20134006.","journal-title":"Ann Surg Oncol"},{"key":"910_CR58","doi-asserted-by":"publisher","first-page":"598555","DOI":"10.3389\/fphar.2020.598555","volume":"11","author":"Y Tsai","year":"2020","unstructured":"Tsai Y, Xia C, Sun Z. The inhibitory effect of 6-gingerol on ubiquitin-specific peptidase 14 enhances autophagy-dependent ferroptosis and anti-tumor in vivo and in vitro. Front Pharmacol. 2020;11:598555.","journal-title":"Front Pharmacol"},{"key":"910_CR59","doi-asserted-by":"publisher","first-page":"101413","DOI":"10.1016\/j.redox.2019.101413","volume":"30","author":"TC Chen","year":"2020","unstructured":"Chen TC, Chuang JY, Ko CY, Kao TJ, Yang PY, Yu CH, et al. AR ubiquitination induced by the curcumin analog suppresses growth of temozolomide-resistant glioblastoma through disrupting GPX4-Mediated redox homeostasis. Redox Biol. 2020;30:101413.","journal-title":"Redox Biol"},{"key":"910_CR60","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1016\/j.apsb.2021.03.036","volume":"11","author":"N Kong","year":"2021","unstructured":"Kong N, Chen X, Feng J, Duan T, Liu S, Sun X, et al. Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1. Acta Pharm Sin B. 2021;11:4045\u201354.","journal-title":"Acta Pharm Sin B"},{"key":"910_CR61","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41419-025-07822-7","volume":"16","author":"X Liu","year":"2025","unstructured":"Liu X, Zeng L, Liu J, Huang Y, Yao H, Zhong J, et al. Artesunate induces ferroptosis in diffuse large B-cell lymphoma cells by targeting PRDX1 and PRDX2. Cell Death Dis. 2025;16:513.","journal-title":"Cell Death Dis"},{"key":"910_CR62","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Tan H, Daniels JD, Zandkarimi F, Liu H, Brown LM, et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem Biol. 2019;26:623\u2013e6339.","journal-title":"Cell Chem Biol"},{"key":"910_CR63","doi-asserted-by":"publisher","first-page":"114905","DOI":"10.1016\/j.ejmech.2022.114905","volume":"245","author":"Y Fang","year":"2023","unstructured":"Fang Y, Tan Q, Zhou H, Xu J, Gu Q. Discovery and optimization of 2-(trifluoromethyl) benzimidazole derivatives as novel ferroptosis inducers in vitro and in vivo. Eur J Med Chem. 2023;245:114905.","journal-title":"Eur J Med Chem"},{"key":"910_CR64","doi-asserted-by":"publisher","first-page":"6610","DOI":"10.7150\/jca.58500","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Guo Y, Li H, Han L. FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma. J Cancer. 2021;12:6610\u20139.","journal-title":"J Cancer"},{"key":"910_CR65","doi-asserted-by":"publisher","first-page":"122411","DOI":"10.1016\/j.lfs.2023.122411","volume":"339","author":"T Takatani-Nakase","year":"2024","unstructured":"Takatani-Nakase T, Ikushima C, Sakitani M, Nakase I. Regulatory network of ferroptosis and autophagy by targeting oxidative stress defense using sulfasalazine in triple-negative breast cancer. Life Sci. 2024;339:122411.","journal-title":"Life Sci"},{"key":"910_CR66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s13402-024-01017-6","volume":"48","author":"Z Yang","year":"2025","unstructured":"Yang Z, Yuan Y, Niu Y, Zuo D, Liu W, Li K, et al. Regulatory factor X1 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by transcriptional regulation of BECN1. Cell Oncol (Dordr). 2025;48:505\u201322.","journal-title":"Cell Oncol (Dordr)"},{"key":"910_CR67","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/cimb47030201","volume":"47","author":"L Wang","year":"2025","unstructured":"Wang L, He X, Shen Y, Chen J, Chen Y, Zhou Z, et al. A novel ferroptosis-related gene prognosis signature and identifying atorvastatin as a potential therapeutic agent for hepatocellular carcinoma. Curr Issues Mol Biol. 2025;47:201.","journal-title":"Curr Issues Mol Biol"},{"key":"910_CR68","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41418-020-00728-1","volume":"28","author":"X Chen","year":"2021","unstructured":"Chen X, Yu C, Kang R, Kroemer G, Tang D. Cellular degradation systems in ferroptosis. Cell Death Differ. 2021;28:1135\u201348.","journal-title":"Cell Death Differ"},{"key":"910_CR69","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s42255-020-0181-1","volume":"2","author":"CKC Ding","year":"2020","unstructured":"Ding CKC, Rose J, Sun T, Wu J, Chen PH, Lin CC, et al. MESH1 is a cytosolic NADPH phosphatase that regulates ferroptosis. Nat Metab. 2020;2:270\u20137.","journal-title":"Nat Metab"},{"key":"910_CR70","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138.","journal-title":"Nature"},{"key":"910_CR71","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature. 2021;593:586\u201390.","journal-title":"Nature"},{"key":"910_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VA Kraft","year":"2019","unstructured":"Kraft VA, Bezjian CT, Pfeiffer S, Ringelstetter L, M\u00fcller C, Zandkarimi F, et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2019;6:41\u201353.","journal-title":"ACS Cent Sci"},{"key":"910_CR73","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/15384101.2019.1597506","volume":"18","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Koppula P, Gan B. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1. Cell Cycle. 2019;18:773\u201383.","journal-title":"Cell Cycle"},{"key":"910_CR74","doi-asserted-by":"publisher","first-page":"88","DOI":"10.7150\/jca.65574","volume":"13","author":"YC Yan","year":"2022","unstructured":"Yan YC, Meng GX, Ding ZN, Liu YF, Chen ZQ, Yan LJ, et al. Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies. J Cancer. 2022;13:88\u2013101.","journal-title":"J Cancer"},{"key":"910_CR75","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3892\/ol.2021.13165","volume":"23","author":"X Tang","year":"2022","unstructured":"Tang X, Chen W, Liu H, Liu N, Chen D, Tian D, et al. Research progress on SLC7A11 in the regulation of cystine\/cysteine metabolism in tumors. Oncol Lett. 2022;23:47.","journal-title":"Oncol Lett"},{"key":"910_CR76","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41419-019-1564-7","volume":"10","author":"S Sui","year":"2019","unstructured":"Sui S, Zhang J, Xu S, Wang Q, Wang P, Pang D. Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells. Cell Death Dis. 2019;10:331.","journal-title":"Cell Death Dis"},{"key":"910_CR77","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.CAN-18-3037","volume":"79","author":"T Liu","year":"2019","unstructured":"Liu T, Jiang L, Tavana O, Gu W. The deubiquitylase OTUB1 mediates ferroptosis via stabilization of SLC7A11. Cancer Res. 2019;79:1913\u201324.","journal-title":"Cancer Res"},{"key":"910_CR78","doi-asserted-by":"publisher","first-page":"165747","DOI":"10.1016\/j.bbadis.2020.165747","volume":"1866","author":"JH Zhu","year":"2020","unstructured":"Zhu JH, De Mello RA, Yan QL, Wang JW, Chen Y, Ye QH, et al. MiR-139-5p\/SLC7A11 inhibits the proliferation, invasion and metastasis of pancreatic carcinoma via PI3K\/Akt signaling pathway. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165747.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"910_CR79","doi-asserted-by":"publisher","first-page":"166788","DOI":"10.1016\/j.bbadis.2023.166788","volume":"1869","author":"J Lee","year":"2023","unstructured":"Lee J, Roh JL. Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer. Biochim Biophys Acta Mol Basis Dis. 2023;1869:166788.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"910_CR80","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","volume":"79","author":"F He","year":"2023","unstructured":"He F, Zhang P, Liu J, Wang R, Kaufman RJ, Yaden BC, et al. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol. 2023;79:362\u201377.","journal-title":"J Hepatol"},{"key":"910_CR81","doi-asserted-by":"publisher","first-page":"100257","DOI":"10.1016\/j.cellin.2025.100257","volume":"4","author":"M Yang","year":"2025","unstructured":"Yang M, Chen X, Hu X, Li H, Huang H, Fang Y, et al. The NF-\u03baB-SLC7A11 axis regulates ferroptosis sensitivity in inflammatory macrophages. Cell Insight. 2025;4:100257.","journal-title":"Cell Insight"},{"key":"910_CR82","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41418-024-01324-3","volume":"31","author":"J Chu","year":"2024","unstructured":"Chu J, Jiang J, Fan X, Liu J, Gao K, Jiang Y, et al. A novel MYC-ZNF706-SLC7A11 regulatory circuit contributes to cancer progression and redox balance in human hepatocellular carcinoma. Cell Death Differ. 2024;31:1333\u201348.","journal-title":"Cell Death Differ"},{"key":"910_CR83","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.7150\/thno.100667","volume":"14","author":"H Shen","year":"2024","unstructured":"Shen H, Qi X, Hu Y, Wang Y, Zhang J, Liu Z, et al. Targeting sirtuins for cancer therapy: epigenetics modifications and beyond. Theranostics. 2024;14:6726\u201367.","journal-title":"Theranostics"},{"key":"910_CR84","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12935-025-03681-6","volume":"25","author":"Y Dai","year":"2025","unstructured":"Dai Y, Cui C, Jiao D, Zhu X. JAK\/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases. Cancer Cell Int. 2025;25:83.","journal-title":"Cancer Cell Int"},{"key":"910_CR85","doi-asserted-by":"publisher","first-page":"858462","DOI":"10.3389\/fonc.2022.858462","volume":"12","author":"N Jyotsana","year":"2022","unstructured":"Jyotsana N, Ta KT, DelGiorno KE. The role of cystine\/glutamate antiporter SLC7A11\/xCT in the pathophysiology of cancer. Front Oncol. 2022;12:858462.","journal-title":"Front Oncol"},{"key":"910_CR86","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/JCI124049","volume":"130","author":"K Hu","year":"2020","unstructured":"Hu K, Li K, Lv J, Feng J, Chen J, Wu H, et al. Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma. J Clin Invest. 2020;130:1752\u201366.","journal-title":"J Clin Invest"},{"key":"910_CR87","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41419-025-08146-2","volume":"16","author":"H Qiu","year":"2025","unstructured":"Qiu H, Liu Y, Zhou H, Hu L, Qi W, Ma H, et al. USP5 regulates ferroptosis in colorectal cancer by targeting the YBX3\/SLC7A11 axis through lysosomal degradation. Cell Death Dis. 2025;16:822.","journal-title":"Cell Death Dis"},{"key":"910_CR88","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.7150\/ijbs.100518","volume":"21","author":"Z Dai","year":"2025","unstructured":"Dai Z, Lin B, Qin M, Lin Y, Wang L, Liao K, et al. METTL3-mediated m6A modification of SLC7A11 enhances nasopharyngeal carcinoma radioresistance by inhibiting ferroptosis. Int J Biol Sci. 2025;21:1837\u201351.","journal-title":"Int J Biol Sci"},{"key":"910_CR89","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, Liu Y, Du T, Yang H, Lei L, Guo M, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc-. Cell Death Differ. 2020;27:662\u201375.","journal-title":"Cell Death Differ"},{"key":"910_CR90","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/j.cub.2018.05.094","volume":"28","author":"X Song","year":"2018","unstructured":"Song X, Zhu S, Chen P, Hou W, Wen Q, Liu J, et al. AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking system Xc-activity. Curr Biol. 2018;28:2388\u2013e23995.","journal-title":"Curr Biol"},{"key":"910_CR91","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/02676591241280371","volume":"40","author":"X Huang","year":"2025","unstructured":"Huang X, Wang Y, Cui X, Yan Q, Xue T, Jing X. Insight into myocardial ischemia-reperfusion injury from the perspective of ferroptosis. Perfusion. 2025;40:1088\u2013102.","journal-title":"Perfusion"},{"key":"910_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10238-025-01933-3","volume":"26","author":"J Lin","year":"2025","unstructured":"Lin J, Chen F, Tang H, Cai X, Huang M, Liang R, et al. CDC26 facilitates ferroptosis through SLC7A11 degradation and cell cycle arrest. Clin Exp Med. 2025;26:11.","journal-title":"Clin Exp Med"},{"key":"910_CR93","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.2147\/CMAR.S551549","volume":"17","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhang Y, Wei J, Li X, Jiang A, Shen Y, et al. The Role of SLC7A11 in Tumor Progression and the Regulation Mechanisms Involved in Ferroptosis. Cancer Manag Res. 2025;17:2393\u2013401.","journal-title":"Cancer Manag Res"},{"key":"910_CR94","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s12094-023-03116-6","volume":"25","author":"J Luo","year":"2023","unstructured":"Luo J, Yu H, Yuan Z, Ye T, Hu B. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells. Clin Transl Oncol. 2023;25:2265\u201376.","journal-title":"Clin Transl Oncol"},{"key":"910_CR95","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41420-023-01517-8","volume":"9","author":"R Xu","year":"2023","unstructured":"Xu R, Wang W, Zhang W. Ferroptosis and the bidirectional regulatory factor p53. Cell Death Discov. 2023;9:197.","journal-title":"Cell Death Discov"},{"key":"910_CR96","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1074\/jbc.RA119.009548","volume":"295","author":"H Nishizawa","year":"2020","unstructured":"Nishizawa H, Matsumoto M, Shindo T, Saigusa D, Kato H, Suzuki K, et al. Ferroptosis is controlled by the coordinated transcriptional regulation of glutathione and labile iron metabolism by the transcription factor BACH1. J Biol Chem. 2020;295:69\u201382.","journal-title":"J Biol Chem"},{"key":"910_CR97","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/antiox14111283","volume":"14","author":"X Zhao","year":"2025","unstructured":"Zhao X, Pan Y, Liang S, Lei Y, Wang Y, Chen L, et al. miR-26a-Targeting SLC7A11 Regulates Erastin-Induced Granulosa Cell Ferroptosis. Antioxid (Basel). 2025;14:1283.","journal-title":"Antioxid (Basel)"},{"key":"910_CR98","doi-asserted-by":"publisher","first-page":"977062","DOI":"10.3389\/fphar.2022.977062","volume":"13","author":"SM Dai","year":"2022","unstructured":"Dai SM, Li FJ, Long HZ, Zhou ZW, Luo HY, Xu SG, et al. Relationship between miRNA and ferroptosis in tumors. Front Pharmacol. 2022;13:977062.","journal-title":"Front Pharmacol"},{"key":"910_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12094-021-02669-8","volume":"24","author":"S Li","year":"2022","unstructured":"Li S, Huang Y. Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy. Clin Transl Oncol. 2022;24:1\u201312.","journal-title":"Clin Transl Oncol"},{"key":"910_CR100","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 2022;42:88\u2013116.","journal-title":"Cancer Commun (Lond)"},{"key":"910_CR101","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.28159","volume":"133","author":"C Louandre","year":"2013","unstructured":"Louandre C, Ezzoukhry Z, Godin C, Barbare J, Mazi\u00e8re J, Chauffert B, et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib. Int J Cancer. 2013;133:1732\u201342.","journal-title":"Int J Cancer"},{"key":"910_CR102","doi-asserted-by":"publisher","first-page":"36021","DOI":"10.18632\/oncotarget.8651","volume":"7","author":"T Sehm","year":"2016","unstructured":"Sehm T, Fan Z, Ghoochani A, Rauh M, Engelhorn T, Minakaki G, et al. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Oncotarget. 2016;7:36021\u201333.","journal-title":"Oncotarget"},{"key":"910_CR103","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41418-019-0394-6","volume":"27","author":"M Wang","year":"2019","unstructured":"Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu N, et al. Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 2019;27:1447.","journal-title":"Cell Death Differ"},{"key":"910_CR104","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41467-020-15109-y","volume":"11","author":"J Cao","year":"2020","unstructured":"Cao J, Chen X, Jiang L, Lu B, Yuan M, Zhu D, et al. DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase. Nat Commun. 2020;11:1251.","journal-title":"Nat Commun"},{"key":"910_CR105","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/jcmm.13008","volume":"21","author":"H Yu","year":"2017","unstructured":"Yu H, Guo P, Xie X, Wang Y, Chen G. Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J Cell Mol Med. 2017;21:648\u201357.","journal-title":"J Cell Mol Med"},{"key":"910_CR106","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41418-022-00943-y","volume":"29","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W. p53 in ferroptosis regulation: the new weapon for the old guardian. Cell Death Differ. 2022;29:895\u2013910.","journal-title":"Cell Death Differ"},{"key":"910_CR107","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57\u201362.","journal-title":"Nature"},{"key":"910_CR108","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2016.09.022","volume":"17","author":"SJ Wang","year":"2016","unstructured":"Wang SJ, Li D, Ou Y, Jiang L, Chen Y, Zhao Y, et al. Acetylation is crucial for p53-mediated ferroptosis and tumor suppression. Cell Rep. 2016;17:366\u201373.","journal-title":"Cell Rep"},{"key":"910_CR109","doi-asserted-by":"publisher","first-page":"8390","DOI":"10.1073\/pnas.1821277116","volume":"116","author":"JIJ Leu","year":"2019","unstructured":"Leu JIJ, Murphy ME, George DL. Mechanistic basis for impaired ferroptosis in cells expressing the African-centric S47 variant of p53. Proc Natl Acad Sci U S A. 2019;116:8390\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"910_CR110","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1038\/s41467-021-23902-6","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen D, Chu B, Yang X, Liu Z, Jin Y, Kon N, et al. iPLA2beta-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4. Nat Commun. 2021;12:3644.","journal-title":"Nat Commun"},{"key":"910_CR111","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei G, Zhuang L, Gan B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024;42:513\u201334.","journal-title":"Cancer Cell"},{"key":"910_CR112","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181\u201392.","journal-title":"Nat Cell Biol"},{"key":"910_CR113","doi-asserted-by":"publisher","first-page":"113110","DOI":"10.1016\/j.celrep.2023.113110","volume":"42","author":"S Lei","year":"2023","unstructured":"Lei S, Chen C, Han F, Deng J, Huang D, Qian L, et al. AMER1 deficiency promotes the distant metastasis of colorectal cancer by inhibiting SLC7A11-and FTL-mediated ferroptosis. Cell Rep. 2023;42:113110.","journal-title":"Cell Rep"},{"key":"910_CR114","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1525-1578(10)60574-0","volume":"7","author":"NA Alam","year":"2005","unstructured":"Alam NA, Olpin S, Rowan A, Kelsell D, Leigh IM, Tomlinson IP, et al. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer. J Mol Diagn. 2005;7:437\u201343.","journal-title":"J Mol Diagn"},{"key":"910_CR115","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal Transduct Target Ther. 2024;9:55.","journal-title":"Signal Transduct Target Ther"},{"key":"910_CR116","doi-asserted-by":"publisher","first-page":"eabj9141","DOI":"10.1126\/sciadv.abj9141","volume":"7","author":"S Egolf","year":"2021","unstructured":"Egolf S, Zou J, Anderson A, Simpson C, Aubert Y, Prouty S, et al. MLL4 mediates differentiation and tumor suppression through ferroptosis. Sci Adv. 2021;7:eabj9141.","journal-title":"Sci Adv"},{"key":"910_CR117","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.molcel.2017.09.009","volume":"68","author":"D Chen","year":"2017","unstructured":"Chen D, Tavana O, Chu B, Erber L, Chen Y, Baer R, et al. NRF2 is a major target of ARF in p53-independent tumor suppression. Mol Cell. 2017;68:224\u2013e2324.","journal-title":"Mol Cell"},{"key":"910_CR118","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s43018-021-00299-1","volume":"3","author":"T Zhang","year":"2022","unstructured":"Zhang T, Sun L, Hao Y, Suo C, Shen S, Wei H, et al. ENO1 suppresses cancer cell ferroptosis by degrading the mRNA of iron regulatory protein 1. Nat Cancer. 2022;3:75\u201389.","journal-title":"Nat Cancer"},{"key":"910_CR119","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1158\/2159-8290.CD-19-1500","volume":"11","author":"X Hong","year":"2021","unstructured":"Hong X, Roh W, Sullivan RJ, Wong KH, Wittner BS, Guo H, et al. The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis. Cancer Discov. 2021;11:678\u201395.","journal-title":"Cancer Discov"},{"key":"910_CR120","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, Thompson CB, Jiang X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A. 2020;117:31189\u201397.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"910_CR121","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker JM, Tasdogan A, Ramesh V, Shen B, Mitchell EC, Martin-Sandoval MS, et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature. 2020;585:113\u20138.","journal-title":"Nature"},{"key":"910_CR122","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang D, Feng Y, Zandkarimi F, Wang H, Zhang Z, Kim J, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell. 2023;186:2748\u2013e276422.","journal-title":"Cell"},{"key":"910_CR123","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41422-023-00788-1","volume":"33","author":"S Qiu","year":"2023","unstructured":"Qiu S, Zhong X, Meng X, Li S, Qian X, Lu H, et al. Mitochondria-localized cGAS suppresses ferroptosis to promote cancer progression. Cell Res. 2023;33:299\u2013311.","journal-title":"Cell Res"},{"key":"910_CR124","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-021-01464-x","volume":"20","author":"E Dai","year":"2021","unstructured":"Dai E, Zhu Z, Wahed S, Qu Z, Storkus WJ, Guo ZS. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Mol Cancer. 2021;20:171.","journal-title":"Mol Cancer"},{"key":"910_CR125","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1158\/2326-6066.CIR-20-0384","volume":"9","author":"JM Drijvers","year":"2021","unstructured":"Drijvers JM, Gillis JE, Muijlwijk T, Nguyen TH, Gaudiano EF, Harris IS, et al. Pharmacologic screening identifies metabolic vulnerabilities of CD8+ T cells. Cancer Immunol Res. 2021;9:184\u201399.","journal-title":"Cancer Immunol Res"},{"key":"910_CR126","doi-asserted-by":"publisher","first-page":"e001369","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova I, Catanzaro E, Van der Meeren L, Turubanova VD, Hammad H, Mishchenko TA, et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J Immunother Cancer. 2020;8:e001369.","journal-title":"J Immunother Cancer"},{"key":"910_CR127","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.scib.2023.02.027","volume":"68","author":"JL Liang","year":"2023","unstructured":"Liang JL, Jin XK, Zhang SM, Huang QX, Ji P, Deng XC, et al. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy. Sci Bull (Beijing). 2023;68:622\u201336.","journal-title":"Sci Bull (Beijing)"},{"key":"910_CR128","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai E, Han L, Liu J, Xie Y, Zeh HJ, Kang R, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat Commun. 2020;11:6339.","journal-title":"Nat Commun"},{"key":"910_CR129","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4049\/jimmunol.1101029","volume":"188","author":"P Kalinski","year":"2012","unstructured":"Kalinski P. Regulation of immune responses by prostaglandin E2. J Immunol. 2012;188:21\u20138.","journal-title":"J Immunol"},{"key":"910_CR130","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/cac2.12321","volume":"42","author":"L Wu","year":"2022","unstructured":"Wu L, Liu F, Yin L, Wang F, Shi H, Zhao Q, et al. The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death. Cancer Commun (Lond). 2022;42:768\u201383.","journal-title":"Cancer Commun (Lond)"},{"key":"910_CR131","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov AA, Yang Q, Dar HH, Tyurina YY, Anthonymuthu TS, Kim R, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16:278\u201390.","journal-title":"Nat Chem Biol"},{"key":"910_CR132","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/eji.200939889","volume":"40","author":"S Recalcati","year":"2010","unstructured":"Recalcati S, Locati M, Marini A, Santambrogio P, Zaninotto F, De Pizzol M, et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol. 2010;40:824\u201335.","journal-title":"Eur J Immunol"},{"key":"910_CR133","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.redox.2022.102463","volume":"56","author":"X Hao","year":"2022","unstructured":"Hao X, Zheng Z, Liu H, Zhang Y, Kang J, Kong X, et al. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2022;56:102463.","journal-title":"Redox Biol"},{"key":"910_CR134","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, et al. Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther. 2021;6:362.","journal-title":"Signal Transduct Target Ther"},{"key":"910_CR135","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim R, Hashimoto A, Markosyan N, Tyurin VA, Tyurina YY, Kar G, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. 2022;612:338\u201346.","journal-title":"Nature"},{"key":"910_CR136","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"JR Cubillos-Ruiz","year":"2015","unstructured":"Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell. 2015;161:1527\u201338.","journal-title":"Cell"},{"key":"910_CR137","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1073\/pnas.1814932116","volume":"116","author":"MD Arensman","year":"2019","unstructured":"Arensman MD, Yang XS, Leahy DM, Toral-Barza L, Mileski M, Rosfjord EC, et al. Cystine-glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity. Proc Natl Acad Sci U S A. 2019;116:9533\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"910_CR138","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, Xiao L, Liu L, Ye L, Su P, Bi E, et al. CD36-mediated ferroptosis dampens intratumoral CD8\u2009+\u2009T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33:1001\u2013e10125.","journal-title":"Cell Metab"},{"key":"910_CR139","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.celrep.2019.10.070","volume":"29","author":"J Muri","year":"2019","unstructured":"Muri J, Thut H, Bornkamm GW, Kopf M. B1 and marginal zone B cells but not follicular B2 cells require Gpx4 to prevent lipid peroxidation and ferroptosis. Cell Rep. 2019;29:2731\u2013e27444.","journal-title":"Cell Rep"},{"key":"910_CR140","doi-asserted-by":"publisher","first-page":"109778","DOI":"10.1016\/j.clim.2023.109778","volume":"256","author":"Q Chen","year":"2023","unstructured":"Chen Q, Xiang M, Gao Z, Lvu F, Sun Z, Wang Y, et al. The role of B-cell ferroptosis in the pathogenesis of systemic lupus erythematosus. Clin Immunol. 2023;256:109778.","journal-title":"Clin Immunol"},{"key":"910_CR141","doi-asserted-by":"publisher","first-page":"175913","DOI":"10.1016\/j.ejphar.2023.175913","volume":"955","author":"Q Li","year":"2023","unstructured":"Li Q, Chen K, Zhang T, Jiang D, Chen L, Jiang J, et al. Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy. Eur J Pharmacol. 2023;955:175913.","journal-title":"Eur J Pharmacol"},{"key":"910_CR142","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.canlet.2006.05.014","volume":"248","author":"T Okada","year":"2007","unstructured":"Okada T, Sawada T, Kubota K. Deferoxamine enhances anti-proliferative effect of interferon-\u03b3 against hepatocellular carcinoma cells. Cancer Lett. 2007;248:24\u201331.","journal-title":"Cancer Lett"},{"key":"910_CR143","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378\u201390.","journal-title":"N Engl J Med"},{"key":"910_CR144","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/ajh.25198","volume":"93","author":"M Ohanian","year":"2018","unstructured":"Ohanian M, Garcia-Manero G, Levis M, Jabbour E, Daver N, Borthakur G, et al. Sorafenib combined with 5-azacytidine in older patients with untreated FLT3-ITD mutated acute myeloid leukemia. Am J Hematol. 2018;93:1136\u201341.","journal-title":"Am J Hematol"},{"key":"910_CR145","doi-asserted-by":"publisher","first-page":"e1002","DOI":"10.14343\/JCSCR.2016.4e1002","volume":"4","author":"SS Kakar","year":"2016","unstructured":"Kakar SS, Worth CA, Wang Z, Carter K, Ratajczak M, Gunjal P. DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancer. J Cancer Stem Cell Res. 2016;4:e1002.","journal-title":"J Cancer Stem Cell Res"},{"key":"910_CR146","doi-asserted-by":"publisher","first-page":"2482514","DOI":"10.1080\/14686996.2025.2482514","volume":"26","author":"N Ito","year":"2025","unstructured":"Ito N, Nabil A, Uto K, Ebara M. Poly (ARTEMA), a novel artesunate-based polymer induces ferroptosis in breast cancer cells. Sci Technol Adv Mater. 2025;26:2482514.","journal-title":"Sci Technol Adv Mater"},{"key":"910_CR147","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1038\/cddis.2013.44","volume":"4","author":"X Qi","year":"2013","unstructured":"Qi X, Zheng L, Lee K, Kim D, Kim C, Cai D, et al. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway. Cell Death Dis. 2013;4:e518\u2013518.","journal-title":"Cell Death Dis"},{"key":"910_CR148","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/21655979.2021.2004980","volume":"13","author":"L Sun","year":"2022","unstructured":"Sun L, Wang H, Xu D, Yu S, Zhang L, Li X. Lapatinib induces mitochondrial dysfunction to enhance oxidative stress and ferroptosis in doxorubicin-induced cardiomyocytes via inhibition of PI3K\/AKT signaling pathway. Bioengineered. 2022;13:48\u201360.","journal-title":"Bioengineered"},{"key":"910_CR149","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1158\/0008-5472.CAN-13-2033","volume":"74","author":"W Fiskus","year":"2014","unstructured":"Fiskus W, Saba N, Shen M, Ghias M, Liu J, Gupta SD, et al. Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemia. Cancer Res. 2014;74:2520\u201332.","journal-title":"Cancer Res"},{"key":"910_CR150","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4143\/crt.2016.572","volume":"50","author":"J Guo","year":"2018","unstructured":"Guo J, Xu B, Han Q, Zhou H, Xia Y, Gong C, et al. Ferroptosis: a novel anti-tumor action for cisplatin. Cancer Res Treat. 2018;50:445\u201360.","journal-title":"Cancer Res Treat"},{"key":"910_CR151","doi-asserted-by":"publisher","first-page":"5951","DOI":"10.1038\/onc.2015.60","volume":"34","author":"L Sleire","year":"2015","unstructured":"Sleire L, Skeie B, Netland I, F\u00f8rde H, Dodoo E, Selheim F, et al. Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc-, leading to glutathione depletion. Oncogene. 2015;34:5951\u20139.","journal-title":"Oncogene"},{"key":"910_CR152","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1523\/JNEUROSCI.5258-04.2005","volume":"25","author":"WJ Chung","year":"2005","unstructured":"Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY, et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci. 2005;25:7101\u201310.","journal-title":"J Neurosci"},{"key":"910_CR153","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3349\/ymj.2021.62.9.843","volume":"62","author":"Q Song","year":"2021","unstructured":"Song Q, Peng S, Sun Z, Heng X, Zhu X. Temozolomide drives ferroptosis via a DMT1-dependent pathway in glioblastoma cells. Yonsei Med J. 2021;62:843\u20139.","journal-title":"Yonsei Med J"},{"key":"910_CR154","doi-asserted-by":"crossref","unstructured":"Cao S, Wei Y, Yue Y, Chen Y, Qian J, Wang D, et al. Rosiglitazone retards the progression of iron overload-induced osteoarthritis by impeding chondrocyte ferroptosis. iScience. 2024:2710526.","DOI":"10.1016\/j.isci.2024.110526"},{"key":"910_CR155","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/cells14030213","volume":"14","author":"Y Wu","year":"2025","unstructured":"Wu Y, Zhang Z, Ren M, Chen Y, Zhang J, Li J, et al. Metformin induces apoptosis and ferroptosis of ovarian cancer cells under energy stress conditions. Cells. 2025;14:213.","journal-title":"Cells"},{"key":"910_CR156","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","volume":"398","author":"MS Carlino","year":"2021","unstructured":"Carlino MS, Larkin J, Long GV. Immune checkpoint inhibitors in melanoma. Lancet. 2021;398:1002\u201314.","journal-title":"Lancet"},{"key":"910_CR157","doi-asserted-by":"publisher","first-page":"e139434","DOI":"10.1172\/JCI139434","volume":"131","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Lim SO, Yan M, Hsu JL, Yao J, Wei Y, et al. TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clin Invest. 2021;131:e139434.","journal-title":"J Clin Invest"},{"key":"910_CR158","doi-asserted-by":"publisher","first-page":"4758","DOI":"10.1038\/s41467-023-40518-0","volume":"14","author":"Y Xue","year":"2023","unstructured":"Xue Y, Lu F, Chang Z, Li J, Gao Y, Zhou J, et al. Intermittent dietary methionine deprivation facilitates tumoral ferroptosis and synergizes with checkpoint blockade. Nat Commun. 2023;14:4758.","journal-title":"Nat Commun"},{"key":"910_CR159","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41422-019-0263-3","volume":"30","author":"G Lei","year":"2020","unstructured":"Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 2020;30:146\u201362.","journal-title":"Cell Res"},{"key":"910_CR160","doi-asserted-by":"publisher","first-page":"102923","DOI":"10.1016\/j.redox.2023.102923","volume":"67","author":"L Yao","year":"2023","unstructured":"Yao L, Hou J, Wu X, Lu Y, Jin Z, Yu Z, et al. Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation. Redox Biol. 2023;67:102923.","journal-title":"Redox Biol"},{"key":"910_CR161","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-023-01429-1","volume":"16","author":"D Wang","year":"2023","unstructured":"Wang D, Li X, Jiao D, Cai Y, Qian L, Shen Y, et al. LCN2 secreted by tissue-infiltrating neutrophils induces the ferroptosis and wasting of adipose and muscle tissues in lung cancer cachexia. J Hematol Oncol. 2023;16:30.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"910_CR162","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41571-026-01128-z","volume":"23","author":"R Kang","year":"2026","unstructured":"Kang R, Liu J, Wang J, Kroemer G, Tang D. Translating ferroptosis into oncology: challenges, opportunities and future directions. Nat Rev Clin Oncol. 2026;23(6):401\u201324.","journal-title":"Nat Rev Clin Oncol"},{"key":"910_CR163","doi-asserted-by":"crossref","unstructured":"Ubellacker JM, Dixon SJ. Prospects for ferroptosis therapies in cancer. Nat Cancer. 2025;6(8):1326-1336.","DOI":"10.1038\/s43018-025-01037-7"},{"key":"910_CR164","doi-asserted-by":"crossref","unstructured":"Qi X, Wang R, Lin Y, Yan D, Zuo J, Chen J, et al. A ferroptosis-related gene signature identified as a novel prognostic biomarker for colon cancer. Front Genet. 2021;12:692426.","DOI":"10.3389\/fgene.2021.692426"},{"key":"910_CR165","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.2147\/IJGM.S341502","volume":"15","author":"Y Lin","year":"2022","unstructured":"Lin Y, Dong Y, Liu W, Fan X, Sun Y. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene SLC7A11 as a Prognostic Biomarker for Cancer. Int J Gen Med. 2022;15:2501\u201313.","journal-title":"Int J Gen Med"},{"key":"910_CR166","doi-asserted-by":"publisher","first-page":"1589423","DOI":"10.3389\/fimmu.2025.1589423","volume":"16","author":"C Liu","year":"2025","unstructured":"Liu C, Liu Q, Lv Y, Chang T, Song S, Ding Y, et al. CPLX1 is a novel prognostic biomarker in CRC correlating with immunotherapy resistance and ferroptosis. Front Immunol. 2025;16:1589423.","journal-title":"Front Immunol"},{"key":"910_CR167","doi-asserted-by":"publisher","first-page":"817643","DOI":"10.3389\/fcell.2022.817643","volume":"10","author":"J Shi","year":"2022","unstructured":"Shi J, Lai D, Zuo X, Liu D, Chen B, Zheng Y, et al. Identification of ferroptosis-related biomarkers for prognosis and immunotherapy in patients with glioma. Front Cell Dev Biol. 2022;10:817643.","journal-title":"Front Cell Dev Biol"},{"key":"910_CR168","doi-asserted-by":"publisher","first-page":"807862","DOI":"10.3389\/fcell.2021.807862","volume":"9","author":"H Wang","year":"2022","unstructured":"Wang H, Cheng Q, Chang K, Bao L, Yi X. Integrated analysis of ferroptosis-related biomarker signatures to improve the diagnosis and prognosis prediction of ovarian cancer. Front Cell Dev Biol. 2022;9:807862.","journal-title":"Front Cell Dev Biol"},{"key":"910_CR169","doi-asserted-by":"publisher","first-page":"1040892","DOI":"10.3389\/fonc.2022.1040892","volume":"12","author":"S Wang","year":"2022","unstructured":"Wang S, Wang H, Zhu S, Li F. Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer. Front Oncol. 2022;12:1040892.","journal-title":"Front Oncol"},{"key":"910_CR170","doi-asserted-by":"publisher","first-page":"1098357","DOI":"10.3389\/fonc.2023.1098357","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang H, Zhu S, Zhou H, Li R, Xia X, Xiong H. Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer. Front Oncol. 2023;13:1098357.","journal-title":"Front Oncol"},{"key":"910_CR171","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/tox.23997","volume":"39","author":"B Cheng","year":"2024","unstructured":"Cheng B, Lai Y, Huang H, Peng S, Tang C, Chen J, et al. MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer. Environ Toxicol. 2024;39:927\u201341.","journal-title":"Environ Toxicol"},{"key":"910_CR172","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.21037\/tcr-21-2157","volume":"11","author":"N Guo","year":"2022","unstructured":"Guo N. Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma. Transl Cancer Res. 2022;11:2688\u201399.","journal-title":"Transl Cancer Res"},{"key":"910_CR173","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1002\/cam4.4716","volume":"11","author":"R Huang","year":"2022","unstructured":"Huang R, Zhang C, Wang X, Zou X, Xiang Z, Wang Z, et al. Identification of FDFT1 as a potential biomarker associated with ferroptosis in ccRCC. Cancer Med. 2022;11:3993\u20134004.","journal-title":"Cancer Med"},{"key":"910_CR174","doi-asserted-by":"publisher","first-page":"675193","DOI":"10.3389\/fmolb.2021.675193","volume":"8","author":"J Song","year":"2021","unstructured":"Song J, Liu Y, Guan X, Zhang X, Yu W, Li Q. A novel ferroptosis-related biomarker signature to predict overall survival of esophageal squamous cell carcinoma. Front Mol Biosci. 2021;8:675193.","journal-title":"Front Mol Biosci"},{"key":"910_CR175","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41388-023-02599-5","volume":"42","author":"AM Minikes","year":"2023","unstructured":"Minikes AM, Song Y, Feng Y, Yoon C, Yoon SS, Jiang X. E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer. Oncogene. 2023;42:848\u201357.","journal-title":"Oncogene"},{"key":"910_CR176","doi-asserted-by":"publisher","first-page":"1188027","DOI":"10.3389\/fmolb.2023.1188027","volume":"10","author":"S Han","year":"2023","unstructured":"Han S, Wang S, Lv X, Li D, Feng Y. Ferroptosis-related genes in cervical cancer as biomarkers for predicting the prognosis of gynecological tumors. Front Mol Biosci. 2023;10:1188027.","journal-title":"Front Mol Biosci"},{"key":"910_CR177","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.2147\/IJGM.S341502","volume":"15","author":"Y Lin","year":"2022","unstructured":"Lin Y, Dong Y, Liu W, Fan X, Sun Y. Pan-cancer analyses confirmed the ferroptosis-related gene SLC7A11 as a prognostic biomarker for cancer. Int J Gen Med. 2022;15:2501\u201313.","journal-title":"Int J Gen Med"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00910-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00910-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00910-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:02:06Z","timestamp":1790362926000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00910-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":177,"alternative-id":["910"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00910-1","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"30 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used ChatGPT (OpenAI) to improve the language, readability, and organization of the manuscript. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article. No generative AI or AI-assisted tools were used to create or modify the figures.","order":2,"name":"Ethics","label":"Declaration of generative AI and AI-assisted technologies in the manuscript preparation process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The figures were prepared using BioRender.com.","order":3,"name":"Ethics","label":"Software used for figure preparation","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}